Display options
Share it on

Front Cell Dev Biol. 2020 Mar 26;8:193. doi: 10.3389/fcell.2020.00193. eCollection 2020.

Regulation of Selective B Cell Autophagy by the Pro-oxidant Adaptor p66SHC.

Frontiers in cell and developmental biology

Anna Onnis, Chiara Cassioli, Francesca Finetti, Cosima T Baldari

Affiliations

  1. Department of Life Sciences, University of Siena, Siena, Italy.

PMID: 32274384 PMCID: PMC7113388 DOI: 10.3389/fcell.2020.00193

Abstract

p66SHC is a pro-oxidant member of the SHC family of protein adaptors that acts as a negative regulator of cell survival. In lymphocytes p66SHC exploits both its adaptor and its reactive oxygen species (ROS)-elevating function to antagonize mitogenic and survival signaling and promote apoptosis. As a result, p66SHC deficiency leads to the abnormal expansion of peripheral T and B cells and lupus-like autoimmunity. Additionally, a defect in p66SHC expression is a hallmark of B cell chronic lymphocytic leukemia, where it contributes to the accumulation of long-lived neoplastic cells. We have recently provided evidence that p66SHC exerts a further layer of control on B cell homeostasis by acting as a new mitochondrial LC3-II receptor to promote the autophagic demise of dysfunctional mitochondria. Here we discuss this finding in the context of the autophagic control of B cell homeostasis, development, and differentiation in health and disease.

Copyright © 2020 Onnis, Cassioli, Finetti and Baldari.

Keywords: B lymphocytes; ROS; autophagy; mitophagy; p66SHC

References

  1. Science. 2007 Feb 2;315(5812):659-63 - PubMed
  2. APMIS. 2007 Feb;115(2):81-103 - PubMed
  3. Lancet. 2018 Apr 14;391(10129):1524-1537 - PubMed
  4. Hum Mol Genet. 2011 May 1;20(9):1726-37 - PubMed
  5. J Clin Invest. 2015 Jun;125(6):2203-10 - PubMed
  6. Immunity. 2005 May;22(5):571-81 - PubMed
  7. Nat Commun. 2015 Apr 10;6:6750 - PubMed
  8. Nature. 2017 Mar 9;543(7644):205-210 - PubMed
  9. Annu Rev Genet. 2009;43:67-93 - PubMed
  10. Immunity. 2006 Aug;25(2):213-24 - PubMed
  11. Immunol Rev. 2012 Sep;249(1):195-204 - PubMed
  12. J Biol Chem. 1994 May 6;269(18):13689-94 - PubMed
  13. J Signal Transduct. 2012;2012:329635 - PubMed
  14. Cell Death Differ. 2016 May;23(5):853-64 - PubMed
  15. Cell Death Differ. 2007 Feb;14(2):338-47 - PubMed
  16. Autophagy. 2019 Feb;15(2):280-294 - PubMed
  17. J Cell Biol. 2010 Apr 19;189(2):211-21 - PubMed
  18. Oncogene. 2018 Mar;37(11):1534-1550 - PubMed
  19. Mutat Res. 2009 Mar 31;674(1-2):131-6 - PubMed
  20. Cell Res. 2014 Jan;24(1):42-57 - PubMed
  21. Haematologica. 2019 Oct;104(10):2040-2052 - PubMed
  22. J Biol Chem. 2011 Jun 3;286(22):19630-40 - PubMed
  23. Cancer Lett. 2008 Jul 18;266(1):84-97 - PubMed
  24. Oncogene. 2002 May 30;21(24):3872-8 - PubMed
  25. J Biol Chem. 2002 Jun 21;277(25):22370-6 - PubMed
  26. Autophagy. 2011 Sep;7(9):1069-70 - PubMed
  27. Acta Pharmacol Sin. 2010 Nov;31(11):1409-20 - PubMed
  28. J Biol Chem. 1997 Oct 31;272(44):28042-9 - PubMed
  29. Apoptosis. 2012 Feb;17(2):174-86 - PubMed
  30. Blood. 2012 Nov 22;120(22):4391-9 - PubMed
  31. Cell Death Differ. 2013 Jan;20(1):31-42 - PubMed
  32. Blood. 2010 May 6;115(18):3726-36 - PubMed
  33. Front Immunol. 2018 Aug 06;9:1801 - PubMed
  34. J Biol Chem. 2006 Apr 14;281(15):10555-60 - PubMed
  35. Nature. 2013 Feb 21;494(7437):323-7 - PubMed
  36. Biochem Pharmacol. 2012 May 15;83(10):1319-30 - PubMed
  37. EMBO J. 1997 Feb 17;16(4):706-16 - PubMed
  38. Immunity. 2008 Jun;28(6):799-809 - PubMed
  39. Genes Dev. 2011 Mar 1;25(5):460-70 - PubMed
  40. Science. 2011 Jan 28;331(6016):456-61 - PubMed
  41. Blood. 2008 May 15;111(10):5017-27 - PubMed
  42. Cell Rep. 2014 Nov 20;9(4):1538-53 - PubMed
  43. J Exp Med. 2018 Feb 5;215(2):399-413 - PubMed
  44. Mitochondrion. 2018 Jul;41:58-65 - PubMed
  45. Autophagy. 2018;14(12):2117-2138 - PubMed
  46. Crit Rev Oncol Hematol. 2011 Dec;80(3):347-68 - PubMed
  47. Respiration. 2011;81(4):265-84 - PubMed
  48. Nature. 1999 Nov 18;402(6759):309-13 - PubMed
  49. BMC Biol. 2013 Jun 21;11:73 - PubMed
  50. Biochem Biophys Res Commun. 2006 Oct 13;349(1):322-8 - PubMed
  51. Mol Cell Biol. 1994 Mar;14(3):1575-81 - PubMed
  52. Drug Metab Pharmacokinet. 2011;26(1):30-46 - PubMed
  53. Nat Immunol. 2013 Mar;14(3):298-305 - PubMed
  54. Science. 2005 Jan 28;307(5709):593-6 - PubMed
  55. Antioxid Redox Signal. 2014 Jan 20;20(3):460-73 - PubMed
  56. Crit Rev Oncol Hematol. 2019 Feb;134:65-70 - PubMed
  57. Cell. 2005 Jul 29;122(2):221-33 - PubMed
  58. Immunol Rev. 2009 Nov;232(1):115-34 - PubMed
  59. Cell. 1992 Jul 10;70(1):93-104 - PubMed
  60. J Exp Med. 2011 Dec 19;208(13):2625-32 - PubMed
  61. Science. 2017 Feb 10;355(6325):641-647 - PubMed
  62. Science. 2002 Mar 29;295(5564):2450-2 - PubMed
  63. Autophagy. 2013 Apr;9(4):528-37 - PubMed
  64. Oncotarget. 2016 Aug 30;7(35):57086-57098 - PubMed
  65. Cancer Lett. 2009 Sep 18;282(2):125-36 - PubMed
  66. Nat Rev Cancer. 2012 Apr 26;12(6):401-10 - PubMed
  67. J Cell Biol. 2010 Dec 27;191(7):1367-80 - PubMed
  68. Mol Cell Biol. 2004 Feb;24(4):1747-57 - PubMed
  69. Blood. 2007 Sep 15;110(6):1730-8 - PubMed
  70. Autophagy. 2008 Apr;4(3):309-14 - PubMed
  71. Nat Med. 2014 May;20(5):503-10 - PubMed
  72. Cell Death Dis. 2014 Feb 20;5:e1068 - PubMed
  73. Int J Biochem Cell Biol. 2004 Dec;36(12):2503-18 - PubMed
  74. Sci Signal. 2014 Feb 18;7(313):ra17 - PubMed

Publication Types